Trade AbbVie ^ABBV

Profits drop at Botox plant in Westport as revenues down by 4pc

Wolfe starts AbbVie at Outperform, says valuation an attractive entry point

AbbVie Target of Unusually Large Options Trading (NYSE:ABBV)

Schulhoff & Co. Inc. Has $5.49 Million Position in AbbVie Inc. (NYSE:ABBV)

Sargent Investment Group LLC Boosts Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Metis Global Partners LLC

ING Groep NV Sells 96,568 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Trading Down 0.5% on Analyst Downgrade

Profits fall by 27% at Abbvie's Botox plant at Westport

Hourglass Capital LLC Sells 31,165 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Bell Bank

AbbVie (NYSE:ABBV) Trading Up 0.1% - Time to Buy?

Oppenheimer & Co. Inc. Has $29.38 Million Position in AbbVie Inc. (NYSE:ABBV)

Souders Financial Advisors Purchases 416 Shares of AbbVie Inc. (NYSE:ABBV)

JPMorgan Chase & Co. Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price

Saturna Capital Corp Purchases 560,808 Shares of AbbVie Inc. (NYSE:ABBV)

Pinnacle Financial Partners Inc Buys 4,441 Shares of AbbVie Inc. (NYSE:ABBV)

Aigen Investment Management LP Invests $1.21 Million in AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Trading Up 0.5% - Here's Why

AbbVie (NYSE:ABBV) Price Target Lowered to $215.00 at Citigroup

BMO Capital Markets Issues Pessimistic Forecast for AbbVie (NYSE:ABBV) Stock Price

Victory Capital Management Inc. Sells 166,072 Shares of AbbVie Inc. (NYSE:ABBV)

Aptus Capital Advisors LLC Buys 14,457 Shares of AbbVie Inc. (NYSE:ABBV)

Health Monitor Network Expands Leadership Team in Response to Continued Growth | Taiwan News | Nov. 12, 2024 23:51

Cumberland Partners Ltd Sells 14,850 Shares of AbbVie Inc. (NYSE:ABBV)

Savvy Advisors Inc. Raises Holdings in AbbVie Inc. (NYSE:ABBV)

Barnett & Company Inc. Lowers Position in AbbVie Inc. (NYSE:ABBV)

Morgan Stanley Cuts AbbVie (NYSE:ABBV) Price Target to $224.00

AbbVie Inc. (NYSE:ABBV) Shares Acquired by Sumitomo Mitsui Trust Group Inc.

Everhart Financial Group Inc. Increases Stock Position in AbbVie Inc. (NYSE:ABBV)

Jeppson Wealth Management LLC Decreases Stock Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by WealthPLAN Partners LLC

Beyond Market Price: Uncovering AbbVie Inc's Intrinsic Value

Apollon Wealth Management LLC Increases Position in AbbVie Inc. (NYSE:ABBV)

Jaffetilchin Investment Partners LLC Boosts Holdings in AbbVie Inc. (NYSE:ABBV)

Company News for Nov 12, 2024 - November 12, 2024 - Zacks.com

Health Care Down as AbbVie, Humana Weigh — Health Care Roundup | Morningstar

Market Today: DOJ Challenges UnitedHealth's Amedisys Deal, AbbVie's Setback

Trending: Bristol-Myers Squibb Shares Up on Setback for AbbVie Schizophrenia Drug | Morningstar

News Highlights: Top Company News of the Day - Monday at 1 PM ET | Morningstar

Stocks making the biggest moves midday: ABBV, TSLA, CI, MS

AbbVie (NYSE:ABBV) Shares Gap Down - Should You Sell?

Ridgecrest Wealth Partners LLC Raises Holdings in AbbVie Inc. (NYSE:ABBV)

News Highlights: Top Company News of the Day - Monday at 11 AM ET | Morningstar

AbbVie Shares Slide, Bristol Myers Shares Rise After Schizophrenia Study Setback — Update | Morningstar

Nations Financial Group Inc. IA ADV Grows Stake in AbbVie Inc. (NYSE:ABBV)

AbbVie Down Over 13%, on Pace for Largest Percent Decrease Since June 2019 — Data Talk | Morningstar

AbbVie Shares Slide, Bristol Myers Shares Rise After Schizophrenia Study Setback | Morningstar

tru Independence LLC Reduces Holdings in AbbVie Inc. (NYSE:ABBV)

Trending: AbbVie Schizophrenia Drug Fails in Mid-Stage Studies | Morningstar

Venturi Wealth Management LLC Raises Stock Holdings in AbbVie Inc. (NYSE:ABBV)

AbbVie Shares Fall Premarket After Schizophrenia Drug Study Failure — Update | Morningstar

CREDIT UPDATE: Bristol Myers (BMY: A2 neg/A) vs AbbVie (ABBV: A3 pos/A-)

AbbVie Tumbles After New Schizophrenia Drug Fails Two Trials

AbbVie Tumbles After New Schizophrenia Drug Fails in Two Trials

AbbVie Says Phase 2 Trials Of Emraclidine In Schizophrenia Did Not Meet Primary Endpoint

AbbVie Provides Update on Phase 2 Results for Emraclidine in Schizophrenia | Morningstar

Kennebec Savings Bank Takes $1.80 Million Position in AbbVie Inc. (NYSE:ABBV)

Tesla, AbbVie lead morning market cap stock movers on Monday By Investing.com

AbbVie shares slip after schizophrenia drug trial misses primary endpoint By Investing.com

AbbVie and Bristol-Myers Squibb: Emraclidine Failure Solidifies Cobenfy Market Position | Morningstar

Bristol Myers Squibb's stock soars after rival AbbVie reports disappointing schizophrenia-drug trial | Morningstar

HTG Investment Advisors Inc. Takes Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Tyler Stone Wealth Management

RKL Wealth Management LLC Purchases 7,899 Shares of AbbVie Inc. (NYSE:ABBV)

Axxcess Wealth Management LLC Sells 2,749 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Liberty Wealth Management LLC

Atria Investments Inc Has $33.69 Million Stake in AbbVie Inc. (NYSE:ABBV)

Assetmark Inc. Acquires 11,893 Shares of AbbVie Inc. (NYSE:ABBV)

Tompkins Financial Corp Has $6.67 Million Stake in AbbVie Inc. (NYSE:ABBV)

Scott & Selber Inc. Sells 6,063 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by TCTC Holdings LLC

Klingman & Associates LLC Grows Stock Position in AbbVie Inc. (NYSE:ABBV)

CWA Asset Management Group LLC Buys New Shares in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by AEGON ASSET MANAGEMENT UK Plc

Fiera Capital Corp Purchases 3,441 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Trading 0.5% Higher - Should You Buy?

Leavell Investment Management Inc. Boosts Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Gold Investment Management Ltd.

AIA Group Ltd Cuts Stock Position in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Walkner Condon Financial Advisors LLC

AbbVie (NYSE:ABBV) Trading Up 0.6% on Analyst Upgrade

Zacks Investment Ideas feature highlights: AbbVie, Visa and Comfort Systems USA - November 8, 2024 - Zacks.com

AbbVie (NYSE:ABBV) Stock Price Down 0.6% - Should You Sell?

Advisors Management Group Inc. ADV Invests $209,000 in AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Sold by Washington Trust Bank

Forte Capital LLC ADV Sells 164 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie Inc. (NYSE:ABBV) Shares Bought by Principal Financial Group Inc.

Montecito Bank & Trust Acquires 6,639 Shares of AbbVie Inc. (NYSE:ABBV)

Advisor Resource Council Makes New Investment in AbbVie Inc. (NYSE:ABBV)

M&G Plc Sells 3,983 Shares of AbbVie Inc. (NYSE:ABBV)

AbbVie (NYSE:ABBV) Upgraded by Argus to Buy Rating

AbbVie Inc. (NYSE:ABBV) Shares Acquired by Dechtman Wealth Management LLC

Dividend Watch: Three Companies Boosting Quarterly Payouts - November 7, 2024 - Zacks.com

7 Growth Stocks for Consistent Income in Retirement

8 Dividend Stocks to Buy Now

7 Stocks That May Provide the Real Solution to The Coronavirus Puzzle

Fed Hints at Tight Policy Amid Global Economic Uncertainty

Dogecoin surges after Elon Musk issues crypto endorsement

Week ahead: Tech rally hinges on Nvidia earnings

Stock Market Today: Indexes Drop as Fed Rate Cuts are still underway

What's Going On With Amazon Stock today? Is AMZN expected to rise?

Dogecoin surges as Trump unveils new government efficiency initiative with Musk andRamaswamy

Japanese Yen to USD: Yen drops to fresh multi-month low against USD

Asia markets today: Nikkei 225 up 0.18%, Hang Seng Index falls by 197 points